Tau protein is involved in the apoptotic process induced by anti-microtubule agents on neuroblastoma cells

S Guise1, D Braguer, M Remacle-Bonnet

  • 1UPRES-A CNRS 6032, Université de la Méditerranée, Marseille, France.

Insights

Anti-microtubule chemotherapy agents induce apoptosis in neuroblastoma cells by promoting tau protein hyperphosphorylation. This tau modification is linked to cell death, suggesting a role in drug-induced apoptosis.

Area of Science:

  • Cell Biology
  • Neuroscience
  • Pharmacology

Background:

  • Paclitaxel and docetaxel are established anti-microtubule and antimitotic drugs.
  • These agents induce apoptosis in various cell types, including bone marrow and epithelial cells.
  • Neuroblastoma is a pediatric cancer with significant unmet therapeutic needs.

Purpose of the Study:

  • To investigate apoptosis induced by anti-microtubule agents in the neuroblastoma SK-N-SH cell line.
  • To specifically examine the role of tau protein, a key Microtubule-Associated Protein (MAP), in this process.
  • To understand the temporal sequence of events leading to apoptosis.

Main Methods:

  • Treatment of SK-N-SH cells with paclitaxel (1 microM) or vinorelbine (0.5 microM).
  • Assessment of cellular events including microtubule bundling, pseudo-aster formation, mitotic block, bcl-2 phosphorylation, tau phosphorylation, phosphatidylserine externalization, and DNA fragmentation.
  • Comparison of drug effects on differentiated, less sensitive SK-N-SH/RA+ cells.
  • Investigation of doxorubicin's effect on tau immunostaining.

Main Results:

  • Paclitaxel treatment induced a cascade of events: microtubule bundling, pseudo-asters, mitotic block, bcl-2 phosphorylation (48h), tau phosphorylation and phosphatidylserine externalization (72h), and DNA fragmentation (96h).
  • Similar results were observed with vinorelbine.
  • Differentiated SK-N-SH/RA+ cells showed reduced tau phosphorylation in response to paclitaxel.
  • Doxorubicin, a non-microtubule targeting agent, also induced tau immunostaining.

Conclusions:

  • Hyperphosphorylated tau is implicated in the apoptotic process of neuroblastoma cells treated with anti-microtubule agents.
  • The findings suggest that tau protein plays a significant role in the cellular events of apoptosis in neuroblastoma.
  • The observed tau hyperphosphorylation may extend to other cytostatic drug treatments.

Related Concept Videos

Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Microtubule Associated Proteins (MAPs)01:42

Microtubule Associated Proteins (MAPs)

Microtubule function and architecture are regulated by an array of specialized proteins called microtubule-associated proteins or MAPs. These proteins are widespread across different organisms and have conserved protein motifs, like the multi-TOG domain for tubulin binding found in the CLASP family of MAPs. Some MAPs are lineage-specific based on their conserved domains. Their functions depend upon the cytoskeletal architecture and cell type they are located within. In-plant cells, a specific...
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...